211 related articles for article (PubMed ID: 9671370)
1. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
Kozek-Langenecker SA; Kettner SC; Oismueller C; Gonano C; Speiser W; Zimpfer M
Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
6. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
[TBL] [Abstract][Full Text] [Related]
8. Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.
Oudemans-van Straaten HM; van Schilfgaarde M; Molenaar PJ; Wester JP; Leyte A
Crit Care; 2009; 13(6):R193. PubMed ID: 19958532
[TBL] [Abstract][Full Text] [Related]
9. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
[TBL] [Abstract][Full Text] [Related]
10. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
Shum HP; Kwan AM; Chan KC; Yan WW
ASAIO J; 2014; 60(4):413-8. PubMed ID: 24727536
[TBL] [Abstract][Full Text] [Related]
11. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
Su T; Jin Q; Liu Z
BMC Nephrol; 2017 Jun; 18(1):208. PubMed ID: 28666474
[TBL] [Abstract][Full Text] [Related]
12. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.
de Pont AC; Oudemans-van Straaten HM; Roozendaal KJ; Zandstra DF
Crit Care Med; 2000 Feb; 28(2):421-5. PubMed ID: 10708177
[TBL] [Abstract][Full Text] [Related]
13. Add-On Prostaglandin E
Buchtele N; Schörgenhofer C; Schwameis M; Jilma B; Schellongowski P; Herkner H; Riss K; Schmid M; Hermann A; Robak O; Nagler B; Traby L; Bojic A; Staudinger T
Am J Respir Crit Care Med; 2022 Jul; 206(2):170-177. PubMed ID: 35426776
[No Abstract] [Full Text] [Related]
14. Possible strategies to prolong circuit life during hemofiltration: three controlled studies.
Baldwin I; Tan HK; Bridge N; Bellomo R
Ren Fail; 2002 Nov; 24(6):839-48. PubMed ID: 12472205
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study.
Martin PY; Chevrolet JC; Suter P; Favre H
Am J Kidney Dis; 1994 Nov; 24(5):806-12. PubMed ID: 7977323
[TBL] [Abstract][Full Text] [Related]
16. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
Tan HK; Baldwin I; Bellomo R
Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
[TBL] [Abstract][Full Text] [Related]
17. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
Palsson R; Laliberte KA; Niles JL
Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
[TBL] [Abstract][Full Text] [Related]
19. Impact of different types of resuscitation fluids on coagulation and continuous venovenous hemofiltration hemocompatibility in a porcine model.
Bedarf JR; Grosch-Ott S; Russ M; Wagner JJ; Hiebl B; Kirschfink M; Unger JK
Ther Apher Dial; 2013 Oct; 17(5):510-23. PubMed ID: 24107280
[TBL] [Abstract][Full Text] [Related]
20. Does continuous heparinization influence platelet function in the intensive care patient?
Boldt J; Müller M; Rothe A; Lenzen P; Hempelmann G
Intensive Care Med; 1997 May; 23(5):567-73. PubMed ID: 9201530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
